000 02757nam a22002897a 4500
003 OSt
005 20260727095226.0
008 260727s2025 |||||||| |||| 00| 0 eng d
050 _aT MTech A58c 2025
100 _aCasaul, Karen L.
245 _aAntimycotic activity of chitosan derived from Litopenaeus vannamei (whiteleg shrimp) shells against candida auris /
_cKaren L. Casaul, [and seven others].
264 _aEmilio Aguinaldo College Cavite :
_bSchool of Medical Technology,
_c2025.
300 _aviii, 103 pages :
_bcolored illustration ;
_c28 cm.
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
504 _aIncludes bibliographic references.
520 _aABSTRACT - - Candida auris is a rising threat in healthcare due to its ability to resist many antifungal drugs and cause serious infections. Because of this, there is an urgent need for alternative treatments. This study aimed to evaluate the antimycotic activity of chitosan extracted from Litopenaeus vannamei (Whiteleg Shrimp) shells against clinical isolates of Candida auris. Chitosan was obtained through demineralization, deproteinization, and deacetylation processes, then confirmed through X-ray diffraction and Fourier-transform infrared spectroscopy. Moreover, to assess antifungal activity, two isolates of C. auris were exposed to different concentrations of chitosan using the broth microdilution method and Kirby-Bauer disk diffusion test. As a result, a distinct dose dependent effect was seen in the data, with greater chitosan concentrations (up to 1000 μg/mL) inhibiting fungal growth more successfully than lower concentrations, particularly in wound isolates. Furthermore, the clinical isolate from the ear canal was resistant to Amphotericin B, although it was still susceptible to the majority of chitosan concentrations, Caspofungin, and Fluconazole. Every treatment was effective on the wound alone. Additionally, these results imply that chitosan, a naturally occurring substance made from seafood waste, may be a viable and sustainable substitute for manufactured antifungal medications, particularly when treating resistant strains such as C. Auris. Opportunities for the advancement of shell-based antifungal drugs in pharmaceutical and medical applications are also presented by this work.
700 _4Author.
_aMontehermoso, Colleen C.
700 _4Author.
_aPaguntalan, Angeline D.
700 _4Author.
_aPakinggan, Louise Jasrhel S.
700 _4Author.
_aRamos, Airish Keight P.
700 _4Author.
_aRogacion, Yzzhi Dominique A.
700 _4Author.
_aValmoria, Athena Joy P.
700 _4Author.
_aZamora, Jade Lynn P.
942 _2lcc
_cTH
_kEAC Cavite-Thesis
999 _c100208
_d100208